Jefferies Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-25,000
Closed -$224K 2734
2016
Q3
$224K Buy
+25,000
New +$178K ﹤0.01% 1910
2016
Q2
Sell
-556,600
Closed -$2.56M 2727
2016
Q1
$2.56M Buy
+556,600
New +$2.24M 0.01% 738

Jefferies Group's RPTP Position: Q4 2016 in Review

Jefferies Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 3,000 shares — an estimated $27K sold.

Jefferies Group first reported a position in RPTP in Q2 2015 and held it in 3 quarters. The position peaked at $1.77M in Q1 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Jefferies Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Jefferies Group sold 3,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $27K.
  • Jefferies Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 3 quarters.
  • Jefferies Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.77M in Q1 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Jefferies Group's 13F filing for Q4 2016, filed 14 Feb 2017.